A

Adverum Biotechnologies
D

ADVM

2.21000
USD
-0.05
(-2.21%)
Market Closed
Volume
3,963
EPS
-6
Div Yield
-
P/E
-0
Market Cap
46,168,520
Related Instruments
A
ABEO
0.07000
(1.14%)
6.23000 USD
ALNY
ALNY
11.51
(3.93%)
304.46 USD
A
ARWR
-0.780
(-4.63%)
16.060 USD
B
BLUE
-0.05000
(-1.00%)
4.93000 USD
C
CRSP
-0.490
(-1.33%)
36.290 USD
E
EDIT
-0.09500
(-5.22%)
1.72500 USD
R
RCKT
-0.11000
(-4.21%)
2.50500 USD
REGN
REGN
-115.23
(-19.04%)
489.98 USD
S
SRPT
-1.030
(-2.67%)
37.600 USD
V
VYGR
-0.07000
(-2.49%)
2.74000 USD
More
News

Title: Adverum Biotechnologies

Sector: Healthcare
Industry: Biotechnology
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.